Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68-Ga PSMA 11 PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy in Patients With Elevated PSA

NCT02673151 is registered in ClinicalTrials.gov with Andrei Iagaru as lead sponsor.

NCT NCT02673151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68-Ga PSMA 11 PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy in Patients With Elevated PSA
Lead sponsor
Andrei Iagaru
Phase
Phase 2/3
Overall status
Completed
Start date
May 20, 2017
Completion date
April 27, 2019
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, psa failure, recurrent prostate carcinoma